People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Healthtech, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| XII Medical, Inc. | — | Healthtech | Series B | $45.1M | $146.0M | 2021 |
| Eikonoklastes Therapeutics, Inc. | — | Pharmaceuticals | Series A | $25.0M | $43.9M | 2020 |
| Invirsa, Inc. | — | Pharmaceuticals | Series A | $9.8M | $9.2M | 2022 |
| Water Assets LLC | — | Other | Pre-Seed | $350K | $1.5M | 2024 |
Samuel Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Samuel Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Duke Rohlen | 1 | 10 |
| Robert Johnson | 1 | 9 |
| Aftab Kherani | 1 | 9 |
| Wayne Embree | 1 | 6 |
| Tony Natale | 1 | 5 |
| Joseph Nolan | 1 | 5 |
| Benjamin Pless | 1 | 5 |
| Thomas Finn | 1 | 3 |
| Josh Nickols | 1 | 3 |
| Akhil Saklecha | 1 | 3 |
| Robert Shalwitz | 1 | 2 |
| Shane Kreidel | 1 | 2 |
| Neel Patel | 1 | 2 |
| Daniel Gottlieb | 1 | 2 |
| JOSEPH RICH | 1 | 2 |
| Zachary Eisen | 1 | 1 |
| Bruce Halpryn | 1 | 1 |
| Kenneth Morand | 1 | 1 |
| Meyer Frucher | 1 | 1 |
| Rachael Wingo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.